Prognostic value of systemic inflammation in patients undergoing 1st-line chemotherapy for metastatic pancreatic cancer: Tokushukai REAl-world Data project

被引：0
|
作者：
Shimoyama, Rai [1 ]
Imamura, Yoshinori [2 ]
Uryu, Kiyoaki [3 ]
Mase, Takahiro [4 ]
Fujimura, Yoshiaki [5 ]
Hayashi, Maki [6 ]
Ohtaki, Megu [7 ]
Ohtani, Keiko [7 ]
Shinozaki, Nobuaki [1 ,8 ]
Minami, Hironobu [2 ]
机构：
[1] Shonankamakura Gen Hosp, Dept Gen Surg, Kamakura, Kanagawa, Japan
[2] Kobe Univ, Grad Sch Med, Dept Med Oncol & Hematol, Kobe, Hyogo, Japan
[3] Yao Tokushukai Hosp, Dept Resp Med & Oncol, Yao, Japan
[4] Ogaki Tokushukai Hosp, Dept Breast Surg, Ogaki, Japan
[5] Tokushukai Informat Syst Inc, Osaka, Japan
[6] Irai Iryo Res Ctr Inc, Kashiwa, Chiba, Japan
[7] deCult Co Ltd, Kurashiki, Okayama, Japan
[8] Gen Inc Assoc Tokushukai, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.340
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P10-2
引用
收藏
页码：S1445 / S1446
页数：2
相关论文
共 50 条
  • [31] Systemic inflammatory markers have independent prognostic value in patients with metastatic testicular germ cell tumours undergoing first-line chemotherapy
    Christian Daniel Fankhauser
    Sophia Sander
    Lisa Roth
    Oliver Gross
    Daniel Eberli
    Tullio Sulser
    Burkhardt Seifert
    Joerg Beyer
    Thomas Hermanns
    British Journal of Cancer, 2018, 118 : 825 - 830
  • [32] Systemic inflammatory markers have independent prognostic value in patients with metastatic testicular germ cell tumours undergoing first-line chemotherapy
    Fankhauser, Christian Daniel
    Sander, Sophia
    Roth, Lisa
    Gross, Oliver
    Eberli, Daniel
    Sulser, Tullio
    Seifert, Burkhardt
    Beyer, Joerg
    Hermanns, Thomas
    BRITISH JOURNAL OF CANCER, 2018, 118 (06) : 825 - 830
  • [33] Treatment sequences in patients with metastatic colorectal cancer in Japan: Real-world evidence of 1st- to 5th-line treatments
    Kagawa, Yoshinori
    Osaka, Tsuyoshi
    Imamura, Toshiki
    Kuwabara, Hiroyo
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 76 - 76
  • [34] Survival outcomes and prognostic factors in real-life practice after treatment with cetuximab in 1st-line metastatic colorectal cancer in the EREBUS cohort
    Fourrier-Reglat, A.
    Rouyer, M.
    Noize, N.
    Bignon, E.
    Jove, J.
    Monnereau, A.
    Cunha, A. Sa
    Francois, E.
    Mitry, E.
    Smith, D.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S554 - S554
  • [35] Real-world evidence evaluating the use of an NK-1 antiemetic in the systemic chemotherapy treatment of metastatic breast cancer.
    Lord, Kevin
    Feinberg, Bruce A.
    Kish, Jonathan
    Laney, Jalyna R.
    Chopra, Dhruv
    Liassou, Djibril
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [36] Real-World Healthcare Resource Utilization Among US Patients With Atrial Fibrillation Receiving Dronedarone versus Ablation as 1st-Line Therapy
    Greene, Stephen J.
    Schilsky, Samantha
    Roberts, Andrew W.
    Kabadi, Shaum M.
    Mckindley, David
    Preblick, Ron
    Rashkin, Jason
    Leeming, Reno
    Sajedian, Renee
    Russo, Andrea M.
    CIRCULATION, 2022, 146
  • [37] Insights into treatment modalities and prognostic factors in pancreatic cancer patients: A 5-year real-world data analysis
    Freitas, A. R. R.
    Goncalves, L.
    Martins, T. S.
    Ferreira, R. M.
    Lobato Rosa, J.
    Zanga, A.
    Moeda, C.
    Sousa, I. M.
    Chaves, A. F.
    Silva Sousa, M. C.
    Vicente, R. S.
    Da Cruz Tomas, T. F.
    ANNALS OF ONCOLOGY, 2024, 35 : S151 - S152
  • [38] Bevacizumab combined with 1st line chemotherapy in elderly patients with metastatic colorectal cancer: Are there good prognostic indicators?
    Borges, C.
    Simoes, J.
    Lemos, C.
    Fernandes, C.
    Sarmento, C.
    Damasceno, M.
    Almeida, D.
    ANNALS OF ONCOLOGY, 2018, 29 : 60 - 60
  • [39] Heterogeneity of first-line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: A real-world evidence study
    Dijksterhuis, Willemieke P. M.
    Verhoeven, Rob H. A.
    Slingerland, Marije
    Mohammad, Nadia Haj
    de Vos-Geelen, Judith
    Beerepoot, Laurens, V
    van Voorthuizen, Theo
    Creemers, Geert-Jan
    van Oijen, Martijn G. H.
    van Laarhoven, Hanneke W. M.
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (07) : 1889 - 1901
  • [40] Survival outcomes and prognostic factors in recurrent and/or metastatic head and neck cancer patients treated with chemotherapy plus cetuximab as first-line therapy in a real-world setting
    Pontes, F.
    Rego, I.
    Domingues, I. C.
    Pinto, L.
    Garcia, R.
    Teixeira, M. M.
    Khoury, L.
    Serra, T.
    Mariano, M.
    Sousa, G. M.
    ANNALS OF ONCOLOGY, 2019, 30
12345